Analysts' ratings for Novo Nordisk (NYSE:NVO) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish |
|---|
| Total Ratings | 1 | 7 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 3 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 3 | 0 | 0 | 0 |
Analysts have recently evaluated Novo Nordisk and provided 12-month price targets. The average target is $160.75, accompanied by a high estimate of $163.00 and a low estimate of $160.00. This upward trend is apparent, with the current average reflecting a 3.93% increase from the previous average price target of $154.67.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds...
8位分析師提供的分析師對諾和諾德（紐約證券交易所代碼：NVO）在上個季度的評級從看漲到看跌不等。
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
| 看漲 | 有點看漲 | 漠不關心 | 有點看跌 | 看跌 |
|---|
| 評分總數 | 1 | 7 | 0 | 0 | 0 |
| 最後 30D | 0 | 1 | 0 | 0 | 0 |
| 1 個月前 | 1 | 3 | 0 | 0 | 0 |
| 2 個月前 | 0 | 0 | 0 | 0 | 0 |
| 3M 之前 | 0 | 3 | 0 | 0 | 0 |
分析師最近對諾和諾...
